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Abstract
In vitro analyses of VZV reactivation from latency in human ganglia have been hampered by the
inability to isolate virus by explantation or cocultivation techniques. Furthermore, attempts to
study interaction of VZV with neurons in experimentally infected ganglion cells in vitro have been
impaired by the presence of non-neuronal cells, which become productively infected and destroy
the cultures. We have developed an in vitro model of VZV infection in which highly pure (>95%)
terminally differentiated human neurons derived from pluripotent stem cells were infected with
VZV. At 2 weeks post-infection, infected neurons appeared healthy compared to VZV-infected
human fetal lung fibroblasts (HFLs), which developed a cytopathic effect (CPE) within 1 week.
Tissue culture medium from VZV-infected neurons did not produce a CPE in uninfected HFLs
and did not contain PCR-amplifiable VZV DNA, but cocultivation of infected neurons with
uninfected HFLs did produce a CPE. The non-productively infected neurons contained multiple
regions of the VZV genome, as well as transcripts and proteins corresponding to VZV immediate-
early, early and late genes. No markers of the apoptotic caspase cascade were detected in healthy-
appearing VZV-infected neurons. VZV infection of highly pure terminally differentiated human
neurons provides a unique in vitro system to study the VZV-neuronal relationship and the
potential to investigate mechanisms of VZV reactivation.
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Introduction
Varicella zoster virus (VZV) is a ubiquitous exclusively human neurotropic
alphaherpesvirus. Primary infection usually produces varicella (chickenpox), after which
virus becomes latent in ganglionic neurons along the entire neuraxis (Gilden et al., 2003).
VZV often reactivates decades later to produce zoster (shingles), characterized by
dermatomal distribution pain and rash. Zoster may be further complicated by chronic pain,
as well as VZV meningoencephalitis, myelopathy, vasculopathy and retinitis (Gilden et al.,
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2011). Prevention of these serious neurological and ocular complications requires a better
understanding of the VZV-host relationship in infected neurons.
Unlike herpes simplex virus (HSV), which is readily recovered by explantation of latently
infected human ganglia in tissue culture or by cocultivation of latently infected human
ganglionic cells with indicator cells, VZV cannot be recovered from latently infected human
ganglia by these techniques (Plotkin et al. 1977). Thus, attempts have been made to establish
a non-lytic infection of human neurons in vitro that can be used to study virus reactivation.
Unfortunately, such attempts have been hampered by the presence in these cultures of non-
neuronal cells, which become productively infected and destroy the entire culture. Herein,
we report the successful non-productive VZV infection of highly pure (>95%) terminally
differentiated human neurons (iCell neurons). iCell neurons are derived from induced
pluripotent stem cells and are a mixture of post-mitotic neural subtypes, comprised primarily
of GABAergic and glutamatergic neurons, with typical physiological characteristics and
responses and positive staining with multiple neuronal markers. Weeks after VZV infection,
analyses of healthy-appearing neurons for cell-free and cell-associated virus, as well as for
the presence of VZV DNA, VZV transcripts, VZV protein and early and late markers of
apoptosis confirmed the non-productive nature of the infection.
Materials and Methods Coating surfaces for neuronal cultures
Tissue culture plates (6-well) (Corning, Tewksbury, MA) were coated with 1 ml poly-L-
ornithine solution (Sigma, St. Louis, MO) for 1 h, washed twice with sterile water followed
by addition of 3 ml of 3.3 ug/ml laminin solution (Sigma) for 1 h at 37°C and used
immediately.
Cells
iCell neurons (Cellular Dynamics International, Madison, WI) are derived from induced
pluripotent stem cells and are a mixture of post-mitotic neural subtypes, comprised primarily
of GABAergic and glutamatergic neurons, with typical physiological characteristics and
responses and positive staining with multiple neuronal markers. iCell neurons obtained in
frozen vials were thawed, seeded at 75,000–100,000 cells per cm2 onto coated surfaces and
maintained in fresh iCell complete maintenance medium at 37°C in 5% CO2. Tissue culture
medium (75% of the total volume) was changed three times per week. Human fetal lung
fibroblasts (HFLs) were cultured in Dulbecco's minimum essential medium (DMEM)
containing 100 U/ml penicillin and 10 μg/ml streptomycin supplemented with 10% fetal
bovine serum (FBS).
Virus infection
To minimize any possibility of overwhelming infection, neurons (~1 × 106) were infected
with 1000 pfu attenuated virus (Zostavax, Merck, Whitehouse Station, NJ) in iCell complete
maintenance medium. HFLs were similarly infected with 1000 pfu VZV and maintained in
DMEM supplemented with 2% FBS.
Attempts to rescue virus from VZV-infected neurons
Two weeks after infection, tissue culture medium from infected neurons was added to HFLs
and cells were monitored for CPE; in addition, 5 ul of 2.5 ml tissue culture medium was
used in real-time PCR with VZV ORF 9- and 63-specific primers. CPE was also monitored
in HFLs co-cultivated with infected neurons released by trypsin treatment and suspended in
DMEM.
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Total nucleic acid extraction
Total nucleic acid was extracted using the mirVANA miRNA extraction kit (Ambion,
Austin, TX). Briefly, cells were scraped in lysis buffer (Ambion) using a rubber policeman.
If present, visible cell clumps were homogenized using a 17–26-gauge needle with a 1-ml
syringe (12–20 strokes) and kept on ice for 10 min. Total nucleic acid was extracted with
acid-phenol chloroform and applied to an affinity column, washed three times, and eluted in
100 ul of PCR-grade water (Teknova, Hollister, CA) at 95°C.
Quantitative real-time PCR
Total nucleic acid was examined by quantitative real-time PCR (RT-qPCR) with VZV-
specific primers (IDT, Coralville, IO) (Table 1) on an Applied Biosystems Fast 7500 and
analyzed using Fast 7500 software. Samples were denatured at 95°C and allowed to elongate
and anneal for 40 cycles at 95°C for 15 s and at 60°C for 30 s. Glyceraldehyde-3-phosphate
dehydrogenase (GPdH) primers and probe were used as a cellular control.
RNA extraction, cDNA synthesis and RT-qPCR
Total nucleic acid (200 ng) was DNase-treated using a Turbo-DNA free kit (Ambion) for 30
min at 37°C, followed by inactivation using inactivation buffer (Ambion) for 5 min at room
temperature with mixing. Sequestered DNase was pelleted by centrifugation at 2000 rpm for
5 min and the supernatant was transferred to a new tube. cDNA synthesis was completed
using the Transcriptor First-Strand cDNA synthesis kit (Roche, Indianapolis, IN). Anchored
oligo-[dT] and random hexamer primers were added and annealed for 10 min at 65°C to
ensure high conversion of mRNA to cDNA. After primer annealing, dNTPs, reverse
transcriptase (RT) reaction buffer and RNase inhibitor were added. Samples were divided
into 2 portions with and without RT to control for any residual DNA. cDNA was stored at
0°C. Both RT-positive and -negative samples were amplified along with wild-type VZV
DNA (106 to 100 genome copies) to compare transcription levels to residual DNA levels.
VZV primers (Table 1) and Taq Universal Probes superscript ROX mix, (Bio-Rad,
Hercules, CA) were combined with 2 μl of cDNA and added to a MicroAmp 96-well plate.
Quantitative real-time PCR was performed as described above. GAPdH primers and probe
were used as a cellular control to confirm cDNA synthesis. VZV gene expression was
presented as a Ct ratio to that of GAPdH.
Immunocytochemistry
Coated coverslips used for neuron propagation were obtained from BD Biosciences (San
Jose, California). Cells were fixed in 4% paraformaldehyde for 20 min at room temperature,
washed three times in PBS, and permeabilized in 0.3% Triton for 10 min. After three rinses
with PBS, cells were either stained or stored at 4°C in PBS. Primary and secondary Alexa-
fluor-conjugated (Invitrogen, Grand Island, NY) antibodies were sequentially added at
dilutions listed in (Table 2), followed by rocking for 1 h at room temperature after each
addition. After 3 washes with PBS, coverslips were sealed using mounting media containing
DAPI (Vectashield, Vector Labs, Burlingame, CA) and visualized on an Eclipse E800
microscope (Nikon, Melville NY).
Results
Human neurons used for infection with VZV are highly pure
iCell neurons were obtained in frozen vials, plated onto 6-well cell culture plates freshly
coated with a base layer of poly-L-ornithine and a top layer of mouse laminin, and
maintained in complete iCell neuron maintenance medium for up to 21 days. After 1–3 days
in tissue culture and before VZV infection (day 0), neurons exhibited a homogeneous
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morphology (Fig. 1a), and more than 95% cells stained positive with neuronal marker anti-
βIII tubulin (Fig. 1d).
VZV-infected neurons did not develop CPE
Neurons and HFLs were infected in parallel. A CPE developed in infected HFLs at 5–7 days
post-infection, while VZV-infected neurons appeared healthy as did uninfected neurons 2
weeks later (Fig. 1b, c). Two weeks after infection, more than 95% cells still stained positive
with anti-βIII tubulin (Fig. 1e, f).
Examination of VZV-infected neurons for cell-free and cell-associated virus
HFLs incubated with the tissue culture medium from VZV-infected neurons did not develop
a CPE. Moreover, no VZV DNA was amplified from the tissue culture medium, indicating
the absence of cell-free virus. In contrast, a CPE did develop in HFLs cocultivated with
trypsinized neurons that had been infected 2 weeks earlier.
VZV DNA and transcripts were present in non-productively infected human neurons
Two weeks after infection, multiple regions of the VZV genome were detected in non-
productively infected neurons (Fig. 2). A search for the presence of VZV transcripts
corresponding to immediate-early (IE), early (E) and late (L) virus genes revealed transcripts
corresponding to VZV ORFs 62, 63, 28, 33, 68 and 31 in infected neurons; each VZV
transcript in neurons was less abundant than in productively infected fibroblasts at the time
of CPE (Fig. 3).
Multiple VZV proteins were detected in non-productively infected neurons
Two weeks after VZV infection of neurons, two VZV IE proteins (Fig. 4), two VZV E
proteins (Fig. 5) and two late VZV proteins (Fig. 6) were detected in neurons that stained
positive for βIII tubulin (Fig. 4a, red). VZV IE 62 was present in the nucleus of neurons
(Fig. 4a, green). VZV IE63 was present in both the nucleus and cytoplasm of infected
neurons (Fig. 4b, c reddish orange). Dual staining with DAPI (blue) revealed VZV early
ORF 29 protein in the nucleus of neurons (Fig. 5a, green), while dual staining with DAPI
(blue) revealed VZV early ORF 36 protein (TK) in the cytoplasm of infected neurons (Fig.
5b, green). Dual staining with VZV late ORF 68 protein (gE) was seen in the cytoplasm of
infected neurons (Fig. 6a, green), and VZV ORF 37 protein (gH) in the cytoplasmic
membrane of infected neurons (Fig. 6b, green).
VZV did not induce apoptosis in neurons
Immunostaining analysis of VZV-infected neurons and fibroblasts for the active form of
caspases 3 and 9 revealed both caspases in VZV-infected fibroblasts, but neither caspase in
healthy-appearing neurons at 2 weeks after VZV infection (Fig. 7).
Discussion
Herein, we report non-productive VZV infection of highly pure terminally differentiated
human neurons, with purity verified by positive β-III tubulin and negative GFAP staining at
the time of VZV infection as well as 2 and 3 weeks later. Two weeks after VZV infection,
neurons appeared healthy and no CPE developed compared to HFLs infected at the same
dose. Tissue culture medium removed from neurons 2 weeks after infection did not produce
a CPE in HFLs, and the absence of cell-free VZV was confirmed by real-time PCR which
did not amplify DNA with VZV-specific primers. In contrast, a CPE developed in HFLs
after cocultivation with VZV-infected neurons. Rescue of VZV from these neurons is
analogous to the isolation of measles virus in tissue culture by cocultivaton of brain cells
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from a patient with subacute sclerosing panencephalitis with Vero cells (Payne et al. 1969),
and isolation of JC virus by cocultivation of brain cells from a patient with progressive
multifocal leukoencephalopathy with human fetal brain cells (Padgett et al. 1971). Overall,
the detection of VZV DNA corresponding to multiple regions of the VZV genome, together
with the presence of transcripts and proteins corresponding to immediate-early, early, and
late VZV genes in VZV-infected neurons that never showed CPE confirm the non-
productive nature of the infection. The absence of both early and late apoptotic markers
indicated that the apoptotic cascade was not operative in neurons non-productively infected
with VZV.
Numerous attempts have been made to establish a model of VZV infection both in vitro and
in vivo. For example, infection of partially purified human fetal sensory neurons with cell-
associated VZV showed more CPE in non-neuronal cells than in neurons (Wigdahl et al.
1986). Analysis of explanted human fetal dorsal root ganglia cocultivated with human fetal
fibroblasts revealed that neurons were resistant to apoptosis (Hood et al. 2003). In a study
using human neural stem cells from fetal brain transplanted into non-obese diabetic SCID
mouse brain and allowed to differentiate in vivo, VZV was found in both neurons and glial
cells after infection (Baiker et al. 2004). The same group demonstrated productive VZV
infection of human fetal dorsal root ganglionic explants containing neurons and non-
neuronal cells; VZV infection peaked at day 4, but dropped dramatically by day 5
(Gowrishankar et al. 2007). In a study using human dorsal root ganglia engrafted under the
kidney capsule of SCID mice and infected with VZV, electron microscopy revealed VZ
virions in neuronal cell nuclei and cytoplasm, but not in satellite cells, and infectious virus
was recovered 14 days after infection; however, 4–8 weeks later, no infectious virus was
released from cells, no virion assembly was detected, and the number of VZV genome
copies was markedly reduced (Zerboni et al. 2005). Infection of neurons derived from
human embryonic stem cells with cell-associated VZV-expressing green fluorescent protein
yielded productive infection although the percent of neurons in the heterogeneous culture
was not provided (Markus et al. 2011), and VZV infection of differentiated neuroblastoma
cells also induced productive infection (Christensen et al., 2011). In addition, VZV was
shown to infect human embryonic stem cell-derived neurons and neurospheres, but not
pluripotent embryonic stem cells or early progenitors (Dukhovny et al., 2012). Overall,
definitive conclusions cannot be drawn since none of the studies above was performed in
sufficiently pure neuronal cultures. Meanwhile, our findings herein verify our earlier
demonstration of non-productive infection of differentiated neurons without evidence of
apoptosis (Pugazhenthi et al. 2011). However, because generation of cultures containing
over 90% neurons was inconsistent, we began infecting iCell neurons with VZV to show
that infection of highly pure cultures of differentiated neurons with VZV produces a non-
productive infection in the absence of apoptosis. This model will allow molecular analysis
of virus-neuronal interaction and studies of the mechanisms of VZV reactivation.
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Fig. 1.
VZV infection of highly pure human neurons did not produce a cytopathic effect.
Terminally differentiated neurons were maintained in tissue culture for up to 21 days. Phase-
contrast microscopy showed healthy-appearing neurons on day 0 (a) and day 14 in culture
(b) as well as 14 days after VZV infection (c). Dual immunofluorescence staining (d–f) with
anti-βIII-tubulin antibody and anti-GFAP antibody revealed positive staining for the
neuronal marker tubulin (red), but not for GFAP (green). Nuclei stained blue with DAPI
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Fig. 2.
VZV DNA was present in non-productively infected human neurons. Two weeks after VZV
infection, DNA was extracted from neurons and quantitated by real-time PCR. Multiple
regions of the VZV genome were detected (black and gray bars are VZV and GAPdH DNA,
respectively)
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Fig. 3.
Multiple VZV transcripts were present in non-productively infected neurons. Two weeks
after infection of neurons, total RNA was extracted, treated with DNAse, and cDNA was
synthesized. Transcripts corresponding to VZV immediate early (IE), early (E) and late (L)
genes were quantified by qPCR as compared to RNA obtained from VZV-infected
fibroblasts at the height of a cytopathic effect (black and gray bars are neurons and HLF,
respectively)
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Fig. 4.
VZV immediate-early proteins were present in non-productively infected human neurons.
Two weeks after VZV infection, neurons attached to laminin-coated coverslips were fixed
and immunostained with anti-tubuiln antibody and anti-VZV IE 62 antibody. Highly pure,
βIII-tubulin-positive human neurons (red, a) contain VZV IE62 in the nucleus (green). (b
and c) show dual immunostained neurons: VZV IE62 protein was seen in the nucleus
(green) and VZV IE 63 in the cytoplasm (red). Scale bar: 20 μm
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Fig. 5.
VZV early proteins were present in non-productively infected human neurons. Two weeks
after VZV infection, neurons attached to laminin-coated coverslips were fixed and
immunostained with anti-VZV ORF 29 antibody and anti-VZV thymidine kinase (TK)
antibody. (Fig. 5a) shows dual immunostaining of DAPI and early VZV ORF29 protein in
the nucleus (green). (Fig. 5b) shows dual immunostaining of DAPI and anti-VZV TK
antibody. VZV TK was seen in the cytoplasm of infected neurons. Scale bars: 20 μm
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Fig. 6.
VZV late proteins gE and gH were detected in non-productively infected human neurons.
Two weeks after VZV infection, neurons attached to laminin-coated coverslips were fixed
and immunostained with anti-VZV gE (a) or anti-VZV gH (b). Dual immunostaining
revealed late VZV gE in the cytoplasm (green, a) and VZV gH in the cytoplasmic
membrane (green, b). Scale bars: 20 μm
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Fig. 7.
Caspase-3 and caspase-9 proteins were not detected in VZV-infected neurons. Two weeks
after VZV infection, neurons attached to laminin-coated coverslips were fixed and dual-
immunostained with anti-caspase 3 (red) and anti-VZV 62 (green) or with anti-caspase 9
(red) and anti-VZV 62 (green) antibodies. Figs. 7a and c show VZV 62 protein (green) but
not caspase-3 (red) or caspase-9 (red) in non-productively infected neurons; Figs. 7b and d
show extensive caspase-3 (red) and caspase-9 (red) and VZV IE 62 (green) staining in VZV-
infected fibroblasts
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Table 1
Primers/probes for real-time PCR
Name Forward primer Reverse primer Probe (FAM) Size (bp)
ORF 4 GTTGTCCGTGGCTCTAAATTTG ACATTCAACACGACCACACTC CCTCTAAAACACCGGCCAGACTGA 144
ORF 9 GGGAGCAGGCGCAATTG TTTGGTGCAGTGCTGAAGGA CAATTGCCAGCGGGAGACC 54
ORF 11 GAGCAAGACAGGATAGTTCAGG AAGATTTTCGGCTAGGTCCAC TCCGTTTTGTGGGATTGGAGACAT 117
ORF 28 CGAACACGTTCCCCATCAA CCCGGCTTTGTTAGTTTTGG TCCAGGTTTTAGTTGATACCA 62
ORF 29 GGCGGAACTTTCGTAACCAA CCCCATTAAACAGGTCAACAAAA TCCAACCTGTTTTGCGGCGGC 66
ORF 62 CCTTGGAAACCACATGATCGT AGCAGAAGCCTCCTCGACAA TGCAACCCGGGCGTCCG 79
ORF 63 GCTTACGCGCTACTTTAATGGAA GCCTCAATGAACCCGTCTTC TGTCCCATCGACCCCCTCGG 67
ORF 66 CCACGTTACCGAACAGATTTATACTG GATCGCTGAATTGCTAAAATGTCA CTAGCTGCAAAGCGCAACCTCCCC 83
ORF 68 GTACATTTGGAACATGCGCG TCCACATATGAAACTCAGCCC AAAACAAGAAACCCTACGCCCGC 140
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Table 2
Antibodies used for immunocytochemistry
Animal Target protein Dilution Supplier
Mouse VZV IE62 1:500 Novus Biologicals, Littleton, CO
Rabbit VZV IE63 1:1000 Mahalingam et al., 1996
Rabbit VZV ORF 29 1:500 Cohrs et al., 2002
Goat VZV thymidine kinase 1:200 Santa Cruz Biotech, Santa Cruz, CA
Mouse VZV glycoprotein E 1:500 Santa Cruz Biotech
Mouse VZV glycoprotein H 1:10 Stipan Jonjić, U. of Rijeka,
Croatia Jürgen Haas, U. of Edinburgh, UK
Rabbit human βIII tubulin 1:1000 Cell Signaling Technology, Danvers, MA
Mouse human glial fibrillary acidic protein (GFAP) 1:300 Cell Signaling Technology
Rabbit human cleaved caspase-3 1:400 Cell Signaling Technology
Rabbit human cleaved caspase-9 1:400 Cell Signaling Technology
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